UNSPSC 51281627: Amikacin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84319SGC3C. European Medicines Agency schedules Amikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05431MIG. Amikacin generally arises in the molecular formula C22H43N5O13.

UNSPSC 51281627 Amikacin, a Commodity code, nominally covers a specific injectable antibiotic, but recent state and local procurement activity tagged under this code shows minimal direct purchasing of amikacin itself. Instead, the code appears in a mix of broader pharmaceutical and medical supply solicitations that include generic drugs, over-the-counter products, emergency medical supplies, and direct-to-manufacturer pharmacy initiatives. The actual work being solicited spans generic multi-source pharmaceuticals distributed through authorized wholesalers, emergency medical and first aid supplies for fire rescue operations, naloxone and drug deactivation systems for community health programs, and exploratory direct-to-manufacturer prescription fulfillment models. Issuing bodies include state health and human services departments, city fire departments, county health offices, and multistate cooperative purchasing alliances serving participating state and local jurisdictions. The code shows activity across administrative health procurement, municipal emergency response supply chains, and cooperative purchasing vehicles rather than narrow acquisition of a single injectable drug.

Geographic activity centers on Florida, Minnesota, Texas, and Oregon, with the most recent opportunities spanning the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products (due March 26, 2026), the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescriptions (due April 3, 2026), the City of Tampa's invitation to bid for medical and first aid supplies for the Fire Department Rescue Division (due March 13, 2026, estimated contract value $700,000), and Seminole County, Florida's IFB for naloxone and drug deactivation systems (due July 26, 2023). The MMCAP and Texas HHS opportunities target manufacturers and pharmacy benefit managers; the Tampa and Seminole County solicitations target medical supply vendors. The code shows broader pharmaceutical and emergency medical procurement activity rather than concentrated demand for amikacin specifically, suggesting the tagging may reflect downstream use rather than direct requisition.